BACKGROUND: The dexamethasone-corticotropin releasing hormone (Dex-CRH) test may differentially predict which depressed patients will respond to antidepressant medication. However, a comprehensive analysis of the safety of this test in psychiatric patients has not previously been performed. METHODS: We conducted a pooled analysis of depressed patients in four clinical studies. Observed and subjectively reported side-effects in 454 patients were collected for 90 minutes following CRH administration. Pre-test electrocardiograms were available in 250 patients to assess cardiac safety. Descriptive statistics were performed to evaluate these safety data. RESULTS: Eight-six (18.9%) subjects experienced no side-effects from the procedure. The mean number of side-effects per subject was 1.4±1.0. The most frequent adverse events were: flushing (n=216, 47.6%), feeling of warmth (144, 31.7%), hyperpnea/tachypnea (108, 23.8%), palpitations (37, 8.1%), and tachycardia (28, 6.2%). Side-effects were consistently mild and brief in duration. There were no serious adverse events. CONCLUSION: The Dex-CRH test produces a mild, predictable side-effect profile, characterized by flushing, feelings of warmth, hyperpnea/tachypnea, palpitations, and tachycardia. These results provide reassurance that the Dex-CRH test is well tolerated in psychiatric patients. Copyright Â
BACKGROUND: The dexamethasone-corticotropin releasing hormone (Dex-CRH) test may differentially predict which depressedpatients will respond to antidepressant medication. However, a comprehensive analysis of the safety of this test in psychiatricpatients has not previously been performed. METHODS: We conducted a pooled analysis of depressedpatients in four clinical studies. Observed and subjectively reported side-effects in 454 patients were collected for 90 minutes following CRH administration. Pre-test electrocardiograms were available in 250 patients to assess cardiac safety. Descriptive statistics were performed to evaluate these safety data. RESULTS: Eight-six (18.9%) subjects experienced no side-effects from the procedure. The mean number of side-effects per subject was 1.4±1.0. The most frequent adverse events were: flushing (n=216, 47.6%), feeling of warmth (144, 31.7%), hyperpnea/tachypnea (108, 23.8%), palpitations (37, 8.1%), and tachycardia (28, 6.2%). Side-effects were consistently mild and brief in duration. There were no serious adverse events. CONCLUSION: The Dex-CRH test produces a mild, predictable side-effect profile, characterized by flushing, feelings of warmth, hyperpnea/tachypnea, palpitations, and tachycardia. These results provide reassurance that the Dex-CRH test is well tolerated in psychiatricpatients. Copyright Â
Authors: Angelika Erhardt; Marcus Ising; Paul Gerson Unschuld; Nikola Kern; Susanne Lucae; Benno Pütz; Manfred Uhr; Elisabeth B Binder; Florian Holsboer; Martin E Keck Journal: Neuropsychopharmacology Date: 2006-07-12 Impact factor: 7.853
Authors: E B Binder; H E Künzel; T Nickel; N Kern; A Pfennig; M Majer; M Uhr; M Ising; F Holsboer Journal: Psychoneuroendocrinology Date: 2008-09-30 Impact factor: 4.905
Authors: Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Doreen Koretz; Kathleen R Merikangas; A John Rush; Ellen E Walters; Philip S Wang Journal: JAMA Date: 2003-06-18 Impact factor: 56.272
Authors: Samuel A Barnes; Douglas J Sheffler; Svetlana Semenova; Nicholas D P Cosford; Anton Bespalov Journal: Biol Psychiatry Date: 2018-03-09 Impact factor: 13.382
Authors: Boadie W Dunlop; Elisabeth B Binder; Joseph F Cubells; Mark M Goodman; Mary E Kelley; Becky Kinkead; Michael Kutner; Charles B Nemeroff; D Jeffrey Newport; Michael J Owens; Thaddeus W W Pace; James C Ritchie; Vivianne Aponte Rivera; Drew Westen; W Edward Craighead; Helen S Mayberg Journal: Trials Date: 2012-07-09 Impact factor: 2.279
Authors: Gioia M Guerrieri; Rivka Ben Dor; Xiaobai Li; Shau-Ming Wei; Pedro E Martinez; Lynnette K Neiman; David R Rubinow; Peter J Schmidt Journal: J Clin Endocrinol Metab Date: 2021-09-27 Impact factor: 6.134